Compare Cassava Sciences Inc (FLNA) vs Innovative Industrial Properties Inc (IIPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Innovative Industrial Properties Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Innovative Industrial Properties Inc trades at $65.3 (market cap $1.84B). The key difference: Innovative Industrial Properties Inc is far larger — about 34.6× Cassava Sciences Inc's market cap, and Innovative Industrial Properties Inc pays a 11.95% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | IIPR | |
|---|---|---|
Market Cap | $53.14M | $1.84B |
Sector | Health | Real Estate |
52-Week High | $4.64 | $64.44 |
52-Week Low | $1.09 | $44.58 |
Enterprise Value | -$33.43M | $2.23B |
Dividend Yield | — | 11.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Filana Therapeutics (FLNA) trades at $1.09, down 5.22% on the day, reflecting persistent operational losses despite recent earnings beats. The stock exhibits a strong bearish technical signal, with moving averages and oscillators aligned negatively. Fundamentally, the company is in a pre-revenue biotech development phase, evidenced by significant negative cash flow from operations (-$32.25M in 2025) and deeply negative profitability metrics (ROE: -79.59%). Recent news highlights continued focus on its Tuberous Sclerosis Complex (TSC)-related epilepsy program.
The outlook is bifurcated: a bullish analyst consensus (8 Buy, 4 Hold, 0 Sell) suggests optimism for the clinical pipeline, while severe financial burn and bearish technicals present substantial near-term risk. Investment opportunity hinges entirely on successful drug development, with significant dilution or financing risk as the company funds operations. The stock is suitable only for high-risk investors comfortable with binary clinical outcomes.
Innovative Industrial Properties (IIPR) trades at $63.83, showing modest daily gains. The technical outlook is bullish based on moving averages, with key support at $61-63 and resistance at $64-66. Fundamentally, the REIT maintains strong gross margins above 88% and a reasonable P/E of 16.22, though revenue declined to $266M in 2025. Recent news highlights successful debt management, including repaying $282M in senior notes and issuing new exchangeable notes, alongside a declared $1.90 quarterly dividend.
Outlook: IIPR presents a high-yield opportunity with a 13% dividend yield, supported by a strengthened balance sheet and potential tailwinds from cannabis rescheduling. Risks include tenant credit quality in the cannabis sector, revenue pressure, and negative cash flow trends. Analyst consensus leans cautious with 36% buy ratings versus 55% hold, suggesting a wait-and-see approach despite the attractive yield.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →
